Huaren Pharmaceutical Co Ltd Financial Flexibility Index
Huaren Pharmaceutical Co Ltd financial flexibility index. Huaren Pharmaceutical Co Ltd (300110) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥93.78 Million (operating CF CN¥86.78 Million minus capex CN¥7.00 Million) represents 0% of total liabilities (CN¥1.97 Billion). See Huaren Pharmaceutical Co Ltd (300110) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Huaren Pharmaceutical Co Ltd (2007–2025)
Financial flexibility index of Huaren Pharmaceutical Co Ltd from 2007 to 2025. Historical Financial Flexibility Index trend for Huaren Pharmaceutical Co Ltd across 19 annual periods. Check Huaren Pharmaceutical Co Ltd (300110) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Huaren Pharmaceutical Co Ltd Financial Flexibility Index by Year (2007–2025)
Huaren Pharmaceutical Co Ltd financial flexibility index by year from 2007 to 2025. Year-by-year free cash flow to debt coverage for Huaren Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Huaren Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.24x | CN¥439.21 Million | CN¥390.23 Million | CN¥1.79 Billion | ▲ +45.0% |
| 2024 | 0.17x | CN¥347.05 Million | CN¥322.36 Million | CN¥2.05 Billion | ▲ +15.4% |
| 2023 | 0.15x | CN¥351.46 Million | CN¥305.60 Million | CN¥2.40 Billion | ▲ +44.2% |
| 2022 | 0.10x | CN¥260.31 Million | CN¥217.98 Million | CN¥2.56 Billion | ▲ +159.0% |
| 2021 | -0.17x | CN¥-550.66 Million | CN¥-578.52 Million | CN¥3.20 Billion | ▼ -496.0% |
| 2020 | 0.04x | CN¥47.22 Million | CN¥-10.74 Million | CN¥1.09 Billion | ▼ -94.1% |
| 2019 | 0.74x | CN¥341.35 Million | CN¥309.33 Million | CN¥461.81 Million | ▲ +121.2% |
| 2018 | 0.33x | CN¥299.79 Million | CN¥254.32 Million | CN¥897.11 Million | ▲ +49.9% |
| 2017 | 0.22x | CN¥298.44 Million | CN¥211.08 Million | CN¥1.34 Billion | ▼ -23.8% |
| 2016 | 0.29x | CN¥350.60 Million | CN¥181.65 Million | CN¥1.20 Billion | ▲ +118.1% |
| 2015 | 0.13x | CN¥175.50 Million | CN¥18.77 Million | CN¥1.31 Billion | ▼ -52.9% |
| 2014 | 0.28x | CN¥325.36 Million | CN¥65.56 Million | CN¥1.14 Billion | ▼ -3.3% |
| 2013 | 0.29x | CN¥267.47 Million | CN¥39.78 Million | CN¥907.56 Million | ▼ -64.5% |
| 2012 | 0.83x | CN¥369.87 Million | CN¥99.44 Million | CN¥445.69 Million | ▼ -84.2% |
| 2011 | 5.24x | CN¥292.36 Million | CN¥59.53 Million | CN¥55.77 Million | ▲ +72.4% |
| 2010 | 3.04x | CN¥144.71 Million | CN¥77.61 Million | CN¥47.60 Million | ▲ +620.5% |
| 2009 | 0.42x | CN¥135.87 Million | CN¥38.63 Million | CN¥321.98 Million | ▼ -35.8% |
| 2008 | 0.66x | CN¥188.07 Million | CN¥57.24 Million | CN¥286.30 Million | ▲ +606.0% |
| 2007 | 0.09x | CN¥16.52 Million | CN¥7.66 Million | CN¥177.50 Million | — |